Bank of America’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18
Closed 9085
2021
Q4
$0 Buy
+18
New +$49 ﹤0.01% 8940
2021
Q2
Sell
-46
Closed 8326
2021
Q1
$0 Buy
+46
New +$131 ﹤0.01% 7963
2020
Q2
Sell
-292
Closed -$1K 7266
2020
Q1
$1K Buy
+292
New +$1.31K ﹤0.01% 6762
2019
Q4
Sell
-1,819
Closed -$11K 7559
2019
Q3
$11K Buy
+1,819
New +$12.2K ﹤0.01% 6714

Other funds holding ETTX

Bank of America's ETTX Position: Q1 2022 in Review

Bank of America sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2022, closing a stake of 18 shares.

Bank of America first reported a position in ETTX in Q3 2019 and held it in 4 quarters. The position peaked at $11K in Q3 2019. 22 funds tracked by Wall St. Rank hold ETTX as of Q1 2022.

  • Bank of America reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2022 after selling out during the quarter.
  • Bank of America sold 18 Entasis Therapeutics Holdings Inc. shares in Q1 2022.
  • Bank of America first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2019 and held it in 4 quarters.
  • Bank of America's Entasis Therapeutics Holdings Inc. position peaked at $11K in Q3 2019.
  • 22 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.